SCHEMBL30454614

SCHEMBL30454614

Cc1n[nH]c2cc(N(C)c3nc(Nc4ccc(S(N)(=O)=O)cc4)ncc3F)ccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 6/20 0.44
CCNT1 O60563 3/20 0.44
CDK1 P06493 3/20 0.44
CCNB1 P14635 3/20 0.44
CDK9 P50750 3/20 0.44
CCNE1 P24864 2/20 0.44
CCNB2 O95067 1/20 0.44
CCNE2 O96020 1/20 0.44
CDK5 Q00535 1/20 0.44
CDK5R1 Q15078 1/20 0.44
CCNB3 Q8WWL7 1/20 0.44
CCNA2 P20248 3/20 0.43
KDR P35968 5/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
PAK1 Q13153 2/20 0.42
CDK7 P50613 2/20 0.42
CCNH P51946 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL589261 1.00 CDK2 (0.44) CDK2CCNT1CDK1CCNB1CDK9
SCHEMBL2873675 0.92 PAK1 (0.48) CDK2CDK1CCNB1CCNB2CDK5
SCHEMBL31672493 0.92 PAK1 (0.48) CDK2CDK1CCNB1CCNB2CDK5
SCHEMBL589156 0.89 PAK1 (0.42) KDRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL30453279 0.86 LRRK2 (0.38) CDK2CCNT1CDK1CCNB1CDK9
SCHEMBL589240 0.86 LRRK2 (0.38) CDK2CCNT1CDK1CCNB1CDK9
SCHEMBL589155 0.85 PAK1 (0.41) CDK2CDK1CDK5KDRPAK1
SCHEMBL5367911 0.85 PAK1 (0.46) CDK2CDK1CDK5KDRCYP3A4
SCHEMBL6993408 0.84 PAK1 (0.40) KDRCYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL589781 0.83 PAK1 (0.43) KDRCYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113181362-B Medicament for preventing and/or treating amyotrophic lateral sclerosis 国立大学法人京都大学 2023-06-13 CN disclosed